论文部分内容阅读
发表在近期出版的《癌症》杂志上的一项研究结果表明,绝经后妇女应用 HMG-CoA(羟甲基戊二酰辅酶 A)抑制剂(statins——他汀类药物)并不增加罹患乳腺癌的风险。相反的是,资料提示长期应用他汀类药物事实上有可能降低乳腺癌风险。
A study published in the recently published issue of The Cancer Journal found that the use of HMG-CoA (statins - statins) in postmenopausal women did not increase the risk of developing breast cancer risks of. In contrast, data suggest that long-term statin use may actually reduce the risk of breast cancer.